DLB: Dolby Laboratories, Inc. Stock

SIC 6794 – Patent Owners and Lessors

Valuation
Market Cap ($M) 4,935.06
Enterprise Value ($M) 4,423.30
Book Value ($M) 2,517.03
Book Value / Share 41.12
Price / Book 1.96
NCAV ($M) 644.23
NCAV / Share 10.53
Price / NCAV 7.66

Profitability (mra)
Return on Invested Capital (ROIC) 0.10
Return on Assets (ROA) 0.09
Return on Equity (ROE) 0.11

Liquidity (mrq)
Quick Ratio 2.84
Current Ratio 2.91

Balance Sheet (mrq) ($M)
Current Assets 1,285.80
Assets 3,158.60
Liabilities 641.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,273.72
Operating Income 264.71
Net Income 261.82
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 327.25
Cash from Investing -286.29
Cash from Financing -287.81

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-03 13D/A Dolby Dagmar 36.60 46.43
01-23 13G Bank of New York Mellon Corp 8.00
11-13 13G/A Kayne Anderson Rudnick Investment Management Llc 0.35 -96.15
09-10 13G/A Morgan Stanley 11.80 53.35

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-01-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 27, 2024 ☐ TRANSITION REPORT PURSUANT
2024-11-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 27, 2024 ☐ TRANSITION REPORT PURSUANT TO SECT
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 28, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 29, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 78,089 251,700 31.02
2025-04-01 57,675 223,302 25.83
2025-03-31 88,242 243,246 36.28
2025-03-28 52,601 189,301 27.79

(click for more detail)

Similar Companies
CXW – CoreCivic, Inc. DEA – Easterly Government Properties, Inc.
DEI – Douglas Emmett, Inc. DLR – Digital Realty Trust, Inc.
DOC – Healthpeak Properties, Inc.


Financial data and stock pages provided by
Fintel.io